All In Biotech

Drug Trial Radar · NCT06550011

Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)

A Phase 1/2a, Open-Label, Multiple-Cohort, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54- VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV)

Last checked: Nov 19, 2026Latest source record: Feb 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

18

Planned (sponsor's estimate)

Start

Aug 7, 2024

Primary completion

Jan 13, 2027

Study completion Jan 16, 2031

Sponsor

Lead sponsor
Avirmax Biopharma IncIndustry
Sponsor type
Industry
First posted
Aug 12, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years, up to 89 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This will be a clinical study to assess initial safety and tolerability of IVT ABI-110 in patients diagnosed with wet macular degeneration (wAMD), including symptomatic macular PCV.

Conditions

  • Neovascular (Wet) AMD

Interventions

  • ABI-110 Low DoseDrug

    Low dose. lower than the safety factor of 10 as recommended by the FDA

  • ABI-110 Medium DoseDrug

    Medium dose

  • ABI-110 High DoseDrug

    High Dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and TolerabilityTime frame: 52 weeks

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • California Retina Consultants

    Bakersfield, California

  • Bay Area Retina Associates

    Walnut Creek, California

  • Retina Consultants of Texas - San Antonio

    San Antonio, Texas

  • Retina Consultants of Texas

    The Woodlands, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.